Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-23-033559
Filing Date
2023-04-28
Accepted
2023-04-28 10:13:53
Documents
3
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT def14a0423_immucell.htm DEF 14A 816627
2 GRAPHIC tbarchart_001.jpg GRAPHIC 303435
3 GRAPHIC tbarchart_002.jpg GRAPHIC 276010
  Complete submission text file 0001213900-23-033559.txt   1616023
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12934 | Film No.: 23861252
SIC: 2835 In Vitro & In Vivo Diagnostic Substances